Navigation Links
EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Date:4/22/2008

o develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

CONTACT:

Ginny Dunn

Associate Director, Corpo
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
2. EntreMed Receives Nasdaq Deficiency Notice
3. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
4. EntreMed Announces 2008 Corporate and Clinical Program Priorities
5. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
6. EntreMed to Present at BIO CEO and Investor Conference
7. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
8. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
9. EntreMed Appoints Senior Vice President of Research and Development
10. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
11. Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bulle...ders of record on December 1, 2009 will receive th...ica, Inc. that was previously approved by Vivakor,...Nevada corporation of which Vivakor owned approxim...record date. The distribution date is still expect...
(Date:12/4/2009)...wire/ -- Stemline Therapeutics, Inc. today announc...R targeting agents, SL-401 and SL-501, in both in... leukemia (CML) have been selected for poster pres...e American Society of Hematology (ASH), to be held...r will be presented by Stemline,s collaborators at...
(Date:12/3/2009)...swire/ -- JourneyLite of Houston, LLC announced ...tients a second surgical option, vertical sleeve ...m that it currently performs. The first sleeve ga...by surgeon partner, Matthew St. Laurent, MD on O...well. ,, The Vertical Sleeve Gastrectomy (also ...
(Date:12/3/2009)...swire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.... update on its European commercial launch of MuGar... debilitating side effect of radiation treatment a...y Access, partner, SpePharm, in six European count...eece and Sweden. Access is conducting pre-marketin...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4
... Claire, Wis. - StrandVision LLC , an online dig...ital signage hardware supplier in Silverdale, Wash...joint marketing agreement. , ,Under the agreement,...ided with a custom login to the Pacific Signage on...hat will help them specify, design and implement d...
...ison, Wis. - If wireless keeps growing at its pre... get their work done, says a wireless channel mana...xander, spoke at a recent Accelerate Madison pro...unications could be a defining feature for corpora...and enhancements increasing, mobility has become t...
...ison, Wis. -- A proposed ban on all human embryon...ate Senate Tuesday, a proposal opposed by many in ...n, known as AB 499, would outlaw not only cloning ... call therapeutic or research cloning, in which an...al subject for the purposes of harvesting stem cel...
Other Biology Technology:Cisco manager touts wireless advantages 2Cloning ban comes before Wisconsin Senate on Tuesday 2Cloning ban comes before Wisconsin Senate on Tuesday 3
(Date:12/2/2009)..., PHILADELPHIA People who smoke their first cigar...er levels of cotinine, a by-product of nicotine wh...moke, regardless of the number of cigarettes smoke... the risk of lung cancer, our results suggest that... especially at risk for lung cancer," said researc...
(Date:12/2/2009)...ILADELPHIA Assurance of a cancer-free status did ...puterized tomography (CT) lung-cancer screening pr...rs wrote in a study published in Cancer Epidemiol...erican Association for Cancer Research. The Decemb...These findings should negate widespread concern in...
(Date:12/2/2009)...Researchers from the University of Georgia College...dual discovery that could open new avenues for tre...vastating single-celled protozoan parasite that co...f whole-genome sequencing, researchers found that ... bacteria: Bacteroides, which are usually found f...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Swine Flu Continues to Wane 62639 1Swine Flu Continues to Wane 62639 2High Risk Women May Often Avoid Using Tamoxifen 62636 1High Risk Women May Often Avoid Using Tamoxifen 62636 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 1Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 3
...ble canaries in the coal mine, well-recognized for...through their presence and abundance in forest lan...bioindicators that the USDA Forest Services Forest...nitors populations of the symbiotic organisms as p...s. , A new report published by the Pacific Nort...
...OR, N.Y. Max Perutz, a pioneer in the field of p...ne of the first to study the molecular structures ...Georgina Ferry, was recently published by Cold Spr... just a scientist, wrote Dr. Richard E. Dickerson ...rotein Science . [H]e was a fine human being with...
...raordinary action of a new cellular therapy came t...ing in a recent study reported in the April issue ... Germany were able to observe the repair action of...od-derived cells capable of developing into adult ... heart tissue and corrected blood flow imbalance w...
Other Biology News:Power of molecular imaging reveals secrets of the heart 2
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human OSCAR Monoclonal Antibody, Unconjugated, Clone 259501 from R&D Systems
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Biology Products: